Skip to main content

Annexon

Annexon Inc is a clinical-stage biopharmaceutical enterprise headquartered in South San Francisco, California. The company discovers and develops novel therapeutics targeting classical complement-mediated autoimmune and neurodegenerative diseases. Its proprietary research pipeline focuses on precision antibody therapies addressing disorders of the brain, eyes, and peripheral nervous systems. Principal revenue is earned through research collaboration agreements, clinical milestone payments, and pharmaceutical development partnerships. The enterprise serves medical researchers, neurology specialists, and clinical healthcare networks. Annexon Inc is publicly traded on the Nasdaq Stock Market.

4 of the funds FundTelligence covers report a position in Annexon.

Legal name
Annexon Inc
Sector
Health Care
Country
United States
Funds holding it
4
Exposure themes
Ageing & Longevity, Healthy Ageing & Function, Vision

Funds holding Annexon

Loading...